By Catherine Eckford (European Pharmaceutical Review)2025-03-13T14:35:41
Approximately 1,000 eligible NHS patients could benefit from the new endometriosis treatment annually.
Already a member? Sign-in
European Pharmaceutical Review delivers authoritative insights, cutting-edge innovations, and expert perspectives that not only inform decisions but drive measurable progress across quality, compliance, and operational excellence.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-04-14T12:32:00Z
Sponsored by Thermo Fisher Scientific
2026-04-14T12:29:00Z
Sponsored by JRS Pharma, In association with Vetter Pharma
2026-03-27T15:37:00
Sponsored by IMA Pharma
2025-11-20T15:00:00
Sponsored by Rapid Micro Biosystems
2025-07-10T12:58:00
Sponsored by FUJIFILM Wako Pure Chemical Corporation
2025-10-08T07:00:00
Sponsored by Entegris
2025-09-19T15:55:00
Sponsored by Sartorius, By Marko Narobe (Sartorius Biosepartions), Michael Gerrero (BridgeBio) and Srivatsan Ramesh (BridgeBio)
2025-07-25T08:10:00
Sponsored by JRS Pharma and Gattefosse, By European Pharmaceutical Review
Site powered by Webvision Cloud